论文部分内容阅读
近年来,“看病贵”成为我国医疗服务中的突出问题,导致看病贵的一个直接推动因素是医疗市场结构的纵向关系所引起的“医药合谋”。医疗市场结构的上下游机构拥有明显的市场势力不对等现象,在此背景下,尽管上游生产企业是完全竞争的,但药品价格却只升不降。在此情况下,政府紧紧强制降低某些药品的价格,并不能从根本上解决问题。核心是要彻底实行医药分家,并加强政府的监管职能,减少政府的管制措施,这样才会有利于医疗改革的有效进行。
In recent years, “expensive medical care ” has become a prominent problem in medical services in our country. A direct driving factor leading to expensive medical treatment is the “medical collusion” caused by the vertical relationship of the medical market structure. Upstream and downstream institutions in the medical market structure have obvious phenomena of unequal market power. Under this background, although the upstream manufacturing enterprises are completely competitive, the prices of medicines only rise and fall. Under such circumstances, the government’s compulsion to lower the prices of certain drugs can not fundamentally solve the problem. The core is to thoroughly implement the separation of medicine and medicine, strengthen the government’s regulatory functions and reduce the government’s control measures so that it will be conducive to the effective implementation of the medical reform.